The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Open accessAbstract
The outbreak of the novel coronavirus in China (SARS-CoV-2) that began in December 2019 presents a significant and urgent threat to global health. This study was conducted to provide the international community with a deeper understanding of this new infectious disease. Epidemiological, clinical features, laboratory findings, radiological characteristics, treatment, and clinical outcomes of 135 patients in northeast Chongqing were collected and analyzed in this study. A total of 135 hospitalized patients with COVID-19 were enrolled. The median age was 47 years (interquartile range, 36-55), and there was no significant gender difference (53.3% men). The majority of patients had contact with people from the Wuhan area. Forty-three (31.9%) patients had underlying disease, primarily hypertension (13 [9.6%]), diabetes (12 [8.9%]), cardiovascular disease (7 [5.2%]), and malignancy (4 [3.0%]). Common symptoms included fever (120 [88.9%]), cough (102 [76.5%]), and fatigue (44 [32.5%]). Chest computed tomography scans showed bilateral patchy shadows or ground glass opacity in the lungs of all the patients. All patients received antiviral therapy (135 [100%]) (Kaletra and interferon were both used), antibacterial therapy (59 [43.7%]), and corticosteroids (36 [26.7%]). In addition, many patients received traditional Chinese medicine (TCM) (124 [91.8%]). It is suggested that patients should receive Kaletra early and should be treated by a combination of Western and Chinese medicines. Compared to the mild cases, the severe ones had lower lymphocyte counts and higher plasma levels of Pt, APTT, d-dimer, lactate dehydrogenase, PCT, ALB, C-reactive protein, and aspartate aminotransferase. This study demonstrates the clinic features and therapies of 135 COVID-19 patients. Kaletra and TCM played an important role in the treatment of the viral pneumonia. Further studies are required to explore the role of Kaletra and TCM in the treatment of COVID-19.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is evidence that the inflammatory serological markers that are usually associated with bacterial infection, such as raised procalcitonin and C-reactive protein, may appear in patients with COVID-19 without a corresponding bacterial co-infection occurring.12 , 13”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [12]
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Clinical characteristics of 2019 novel coronavirus infection in ChinaPreprint
Guan, W., Ni, Z., Hu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.06.20020974 · Cited by 1,485
Self-citationAssiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam
Lan, P. T., Nguyễn, T. V., Lương, Q. C., Nguyen, T. V., Nguyen, H. T., Le, H. Q., Nguyen, T. T., Cao, T. M., & Pham, Q. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001272 · Cited by 1,164
Research works printed but not linked: 2
- General Office of the National Health and Family PlanningCommission, 2020, Diagnosis and treatment of novel coronavirus pneumonia (trial version 5), Chin J Integr Med, 3
- Wang F, 2018, Effects of matrine combied with baicalin on mouse pneumonia induced by LPS, Chin Pharmacol Bull, 8, 1105
Cited by
Sorted by citations
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Azkur, A. K., Akdiş, M., Azkur, D., Sokołowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K. C., & Akdiş, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,149
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964
Huang, I., Lim, M. A., & Pranata, R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.018 · Cited by 974
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.044 · Cited by 814
Smoking is associated with COVID-19 progression: a meta-analysis
Patanavanich, R., & Glantz, S. A. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa082 · Cited by 765
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J., Dong, X., Liu, G., & Gao, Y. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 782
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662
Grant, M. C., Geoghegan, L., Arbyn, M., Mohammed, Z., McGuinness, L. A., Clarke, E. L., & Wade, R. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234765 · Cited by 676
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Malik, P., Patel, U. K., Mehta, D., Patel, N., Kelkar, R., Akrmah, M., Gabrilove, J. L., & Sacks, H. S. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111536 · Cited by 618
Henry, B. M., Aggarwal, G., Wong, J., Benoit, S. W., Vikse, J., Plebani, M., & Lippi, G. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.05.073 · Cited by 626
Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620937175 · Cited by 630
Pijls, B. G. C. W., Jolani, S., Atherley, A., Derckx, R. T., Dijkstra, J. I. R., Franssen, G. H. L. M., Hendriks, S., Richters, A., Jellema, A., Zalpuri, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044640 · Cited by 596
Musuuza, J., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., & Safdar, N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251170 · Cited by 565
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Reddy, R. K., Charles, W. N., Sklavounos, A., Dutt, A., Seed, P. T., & Khajuria, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26389 · Cited by 478
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Mani, J. S., Johnson, J. B., Steel, J. C., Broszczak, D. A., Neilsen, P. M., Walsh, K. B., & Naiker, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197989 · Cited by 451
Neurological Manifestations of COVID‐19: A systematic review and current update
Whittaker, A., Anson, M., & Harky, A. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13266 · Cited by 441
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
Lippi, G., Wong, J., & Henry, B. M. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15272 · Cited by 433
Singh, A. K., Gillies, C., Singh, R., Singh, A., Chudasama, Y., Coles, B., Seidu, S., Zaccardi, F., Davies, M. J., & Khunti, K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14124 · Cited by 427
Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.029 · Cited by 427
Self-citationde Almeida-Pititto, B., Dualib, P. M., Zajdenverg, L., Dantas, J. R., de Souza, F. D., Rodacki, M., Bertoluci, M. C., & Brazilian Diabetes Society Study Group (SBD) (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00586-4 · Cited by 391
Wang, X., Fang, X., Cai, Z., Wu, X., Gao, X., Min, J., & Wang, F. (2020) · Research · doi:10.34133/2020/2402961 · Cited by 400
D-dimer level in COVID-19 infection: a systematic review
Rostami, M., & Mansouritorghabeh, H. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1831383 · Cited by 383
Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)
Lippi, G., South, A. M., & Henry, B. M. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220922255 · Cited by 376
Simons, D., Shahab, L., Brown, J., & Perski, O. (2020) · Addiction · doi:10.1111/add.15276 · Cited by 387
Pranata, R., Huang, I., Lim, M. A., Wahjoepramono, E. J., & July, J. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104949 · Cited by 364
Pranata, R., Lim, M. A., Huang, I., Raharjo, S. B., & Lukito, A. A. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320926899 · Cited by 355
McGurnaghan, S. J., Weir, A., Bishop, J., Kennedy, S., Blackbourn, L. A. K., McAllister, D., Hutchinson, S. J., Caparrotta, T. M., Mellor, J., Jeyam, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30405-8 · Cited by 339
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 365
Racial and Gender-Based Differences in COVID-19
Kopel, J. J., Perisetti, A., Roghani, A., Aziz, M., Gajendran, M., & Goyal, H. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00418 · Cited by 324
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies
Minno, A. D., Ambrosino, P., Calcaterra, I. L., & Minno, M. N. D. D. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1715456 · Cited by 300
Farsalinos, K. E., Barbouni, A., & NIAURA, R. S. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02355-7 · Cited by 303
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
Bertolini, A., van de Peppel, I. P., Bodewes, F. A. J. A., Moshage, H. J., Fantin, A., Farinati, F., Fiorotto, R., Jonker, J. W., Strazzabosco, M., Verkade, H. J., et al. (2020) · Hepatology · doi:10.1002/hep.31480 · Cited by 295
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Changeux, J., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · Comptes Rendus Biologies · doi:10.5802/crbiol.8 · Cited by 316
Hasan, S. S., Capstick, T., Ahmed, R., Kow, C. S., Mazhar, F., Merchant, H. A., & Zaidi, S. T. R. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1804365 · Cited by 283
COVID–19-associated coagulopathy: An exploration of mechanisms
Colling, M. E., & Kanthi, Y. M. (2020) · Vascular Medicine · doi:10.1177/1358863x20932640 · Cited by 283
Mantovani, A., Byrne, C. D., Zheng, M., & Targher, G. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.014 · Cited by 269
Diabetes and COVID-19: A systematic review on the current evidences
Abdi, A., Jalilian, M., Sarbarzeh, P. A., & Vlaisavljević, Ž. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108347 · Cited by 275
Huang, Y., Bai, C., He, F., Xie, Y., & Zhou, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104939 · Cited by 261
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
Dong, M., Zhang, J., Ma, X., Tan, J., Chen, L., Liu, S., Xin, Y., & Zhuang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110678 · Cited by 262
Sallam, M., Dababseh, D., Yaseen, A. I. B., Al-Haidar, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17144915 · Cited by 259
Elshazli, R. M., Toraih, E. A., Elgaml, A., El‐Mowafy, M., El‐Mesery, M., Amin, M. N., Hussein, M. H., Killackey, M. T., Fawzy, M. S., & Kandil, E. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238160 · Cited by 261
Laboratory findings of COVID-19: a systematic review and meta-analysis
Zu-li, Z., Hou, Y., Li, D., & Li, F. (2020) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2020.1768587 · Cited by 248
Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
Kulkarni, A. V., Kumar, P., Tevethia, H. V., Premkumar, M., Arab, J. P., Cândia, R., Talukdar, R., Sharma, M., Qi, X., Rao, P. N., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15916 · Cited by 250
Islam, M. S., Aziz, M. A., Aziz, M. A., Aka, T. D., & Jakaria, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05684 · Cited by 253
Laboratory findings in COVID-19 diagnosis and prognosis
Pourbagheri‐Sigaroodi, A., Bashash, D., Fateh, F., & Abolghasemi, H. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.019 · Cited by 250
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
Li, X., Zhong, X., Wang, Y., Zeng, X., Luo, T., & Liu, Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250602 · Cited by 236
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Giannakoulis, V. G., Papoutsi, E., & Siempos, I. Ι. (2020) · JCO Global Oncology · doi:10.1200/go.20.00225 · Cited by 226
Akbari, H., Tabrizi, R., Lankarani, K. B., Aria, H., Vakili, S., Asadian, F., Noroozi, S., Keshavarz, P., & Faramarz, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118167 · Cited by 224
Sharifian, M., Huot, P., Osherov, M., Wen, D., Saveriano, A., Giacomini, P. S., Antel, J. P., & Mowla, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117085 · Cited by 230
Hariyanto, T. I., Japar, K. V., Kwenandar, F., Damay, V., Siregar, J. I., Lugito, N. P. H., Tjiang, M. M., & Kurniawan, A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.12.076 · Cited by 221
Review article: COVID‐19 and liver disease—what we know on 1st May 2020
Garrido, I., Liberal, R., & Macedo, G. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15813 · Cited by 223
Dorjee, K., Kim, H., Bonomo, E., & Dolma, R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243191 · Cited by 216
Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis
Feng, X., Li, S., Sun, Q., Zhu, J., Chen, B., Xiong, M., & Cao, G. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00301 · Cited by 215
Self-citationAziz, M., Fatima, R., Lee‐Smith, W., & Assaly, R. (2020) · Critical Care · doi:10.1186/s13054-020-02995-3 · Cited by 211
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
Favas, T. T., Dev, P., Chaurasia, R. N., Chakravarty, K., Mishra, R., Joshi, D., Mishra, V. N., Kumar, A., Singh, V. K., Pandey, M., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04801-y · Cited by 218
Farsalinos, K. E., Barbouni, A., & NIAURA, R. S. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02457-2 · Cited by 206
Sanchez‐Ramirez, D. C., & Mackey, D. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106096 · Cited by 201
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis
Yang, X., Jin, Y., Li, R., Zhang, Z., Sun, R., & Chen, D. (2020) · Critical Care · doi:10.1186/s13054-020-03065-4 · Cited by 197
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis
Li, J.-W., Han, T., Woodward, M., Anderson, C. S., Zhou, H., Chen, Y.-D., & Neal, B. C. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.008 · Cited by 193
Medicinal Plants as Sources of Active Molecules Against COVID-19
Benarba, B., & Pandiella, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01189 · Cited by 191
Aggarwal, G., Cheruiyot, I., Aggarwal, S., Wong, J., Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100617 · Cited by 189
Oyelade, T., Alqahtani, J. S., & Canciani, G. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5020080 · Cited by 194
Xiao, L., Sakagami, H., & Miwa, N. (2020) · Viruses · doi:10.3390/v12050491 · Cited by 193
Association of elevated inflammatory markers and severe COVID-19
Ji, P., Zhu, J., Zhong, Z., Li, H., Pang, J., Li, B., & Zhang, J. (2020) · Medicine · doi:10.1097/md.0000000000023315 · Cited by 183
Self-citationMusculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients
Cipollaro, L., Giordano, L., Padulo, J., Oliva, F., & Maffulli, N. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01702-w · Cited by 178
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
Cevallos, E. C., Fuentes, X. F., Campioli, C. C., O’Horo, J. C., Saleh, O. A., Odeyemi, Y., Yadav, H., & Temesgen, Z. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.10.054 · Cited by 172
Xiong, M., Liang, X., & Wei, Y. (2020) · British Journal of Haematology · doi:10.1111/bjh.16725 · Cited by 174
Maatman, T. K., Jalali, F., Feizpour, C. A., Douglas, A., McGuire, S. P., Kinnaman, G., Hartwell, J. L., Maatman, B. T., Kreutz, R. P., Kapoor, R., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004466 · Cited by 174
Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection
Korkmaz, M. Ö., Eğilmez, O. K., Özçelik, M. A., & Güven, M. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06396-8 · Cited by 186
Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis
Abdullahi, A., Candan, S. A., Abba, M. A., Bello, A. H., Alshehri, M. A., Victor, E. A., Umar, N. A., & Kundakci, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00687 · Cited by 171
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
Hessami, A., Shamshirian, A., Heydari, K., Pourali, F., Alizadeh‐Navaei, R., Moosazadeh, M., Abrotan, S., Shojaie, L., Sedighi, S., Shamshirian, D., et al. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.10.022 · Cited by 189
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis
Gülşen, A., Yiğitbaş, B. A., Uslu, B., Drömann, D., & Kılınç, O. (2020) · Pulmonary Medicine · doi:10.1155/2020/7590207 · Cited by 172
Chidambaram, V., Tun, N. L., Haque, W. Z., Majella, M. G., Sivakumar, R. K., Kumar, A., Hsu, A. T., Ishak, I. A., Nur, A. A., Ayeh, S. K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241541 · Cited by 176
Farsalinos, K. E., Barbouni, A., Poulas, K. A., Polosa, R., Caponnetto, P., & NIAURA, R. S. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320935765 · Cited by 178
Follow-up studies in COVID-19 recovered patients - is it mandatory?
Vellingiri, B., Iyer, M., Subramaniam, M., Jayaramayya, K., Kumar, N. S., Laldinmawii, G., Narayanasamy, A., Reddy, P. J. K., Sivaprakash, P., Kanchana, S., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139021 · Cited by 174
Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A. R., & Noubiap, J. J. (2020) · Biomarker Research · doi:10.1186/s40364-020-00217-0 · Cited by 168
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
Mantovani, A., Beatrice, G., & Dalbeni, A. (2020) · Liver International · doi:10.1111/liv.14465 · Cited by 168
Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia
Torabi, A., Mohammadbagheri, E., Dilmaghani, N. A., Bayat, A., Fathi, M., Vakili, K. G., Alizadeh, R., Rezaeimirghaed, O., Hajiesmaeili, M., Ramezani, M., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00249 · Cited by 168
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Huang, G., Kovalic, A. J., & Graber, C. J. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201160 · Cited by 168
Self-citationYouTube as a source of medical information on the novel coronavirus 2019 disease (COVID-19) pandemic
D'Souza, R. S., D’Souza, S., Strand, N. H., Anderson, A. L., Vogt, M. N. P., & Olatoye, O. O. (2020) · Global Public Health · doi:10.1080/17441692.2020.1761426 · Cited by 166
Boukhatem, M. N., & Setzer, W. N. (2020) · Plants · doi:10.3390/plants9060800 · Cited by 162
Ford, N. P., Vitória, M., Rangaraj, A., Norris, S. L., Calmy, A., & Doherty, M. C. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25489 · Cited by 157
Jutzeler, C. R., Bourguignon, L., Weis, C., Tong, B., Wong, C., Rieck, B., Pargger, H., Tschudin‐Sutter, S., Egli, A., Borgwardt, K. M., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101825 · Cited by 168
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Piñana, J. L., Martino, R., García‐García, I., Parody, R., Morales, M. D., Callejo, G. B., Gómez-Catalán, I., Coll, R., de la Fuente, I., Luna, A., et al. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00177-z · Cited by 155
Cardiac manifestations in COVID‐19 patients—A systematic review
Shafì, A. M. A., Shaikh, S. A., Shirke, M., Iddawela, S., & Harky, A. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14808 · Cited by 153
Du, Y., Zhou, N., Zha, W., & Lv, Y. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.009 · Cited by 159
Patanavanich, R., & Glantz, S. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-11579-x · Cited by 152
Parohan, M., Yaghoubi, S., & Seraj, A. (2020) · Hepatology Research · doi:10.1111/hepr.13510 · Cited by 157
Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes
Galbadage, T., Peterson, B. M., Awada, J., Buck, A., Ramirez, D. A., Wilson, J., & Gunasekera, R. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00348 · Cited by 147
Elevated d-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019
Shah, S., Shah, K. B., Patel, S., Patel, F. S., Osman, M., Velagapudi, P., Turagam, M. K., Lakkireddy, D., & Garg, J. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000330 · Cited by 149
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
James, P. T., Ali, Z., Armitage, A. E., Bonell, A., Cerami, C., Drakesmith, H., Jobe, M., Jones, K. S., Liew, Z., Moore, S. E., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab059 · Cited by 147
COVID-19 and its cardiovascular effects: a systematic review of prevalence studies
Pellicori, P., Doolub, G., Wong, C. M., Lee, K. S., Mangion, K., Ahmad, M., Berry, C., Squire, I. B., Lambiase, P. D., Lyon, A. R., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013879 · Cited by 151
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P., & Nemati, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12967 · Cited by 155
Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2
Yu, S., Zhu, Y., Xu, J., Yao, G., Zhang, P., Wang, M., Zhao, Y., Lin, G., Chen, H., Chen, L., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153364 · Cited by 152
Curcumin (a constituent of turmeric): New treatment option against COVID‐19
Babaei, F., Nassiri‐Asl, M., & Hosseinzadeh, H. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1858 · Cited by 146
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19
Bao, J., Li, C., Zhang, K., Kang, H., Chen, W., & Gu, B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.009 · Cited by 143
Lim, M. A., Pranata, R., Huang, I., Yonas, E., Soeroto, A. Y., & Supriyadi, R. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120938573 · Cited by 145
Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review
Weng, L., Su, X., & Wang, X. (2021) · Journal of Pain Research · doi:10.2147/jpr.s269206 · Cited by 156
Metadata
- Authors
- Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., Huang, X., Lv, J., Luo, Y., Shen, L., Yang, H., Huang, G., & Yang, R.
- Affiliations
- Chongqing University (CN)
- Chongqing Medical University (CN)
- Pharmaceutical Department of Chongqing Three Gorges Central Hospital Chongqing University Three Gorges Hospital Chongqing China
- Corresponding author
- Zheng, Yu
- Li, Boqun
- Hu, Yanjun
- ORCID
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-04
- Volume
- 92
- Issue
- 7
- Pages
- 797-806
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- PMC
- PMC7228368
- OpenAlex
- W3012673820
- Cited by
- 982
- References
- 27
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 40 · 2023: 75 · 2022: 125 · 2021: 299 · 2020: 427
- FWCI
- 30.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Medical Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundamental Research Funds for the Central Universities (2020CDJYGRH-YJ03)
- National Social Science Foundation (15BGL191)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, clinical features, lopinavir/ritonavir, ritonavir, traditional Chinese medicine, antiviral therapy, corticosteroids, antibiotic therapy, interferon, viral pneumonia, chest CT findings, ground-glass opacities, lymphocyte count, D-dimer, lactate dehydrogenase, C-reactive protein, comorbidities, hospitalized patients
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Adolescent, Adrenal Cortex Hormones, Adult, Aged, Anti-Bacterial Agents, Antiviral Agents, Cardiovascular Diseases, China, Cough, Diabetes Mellitus, Drug Combinations, Drugs, Chinese Herbal, Fatigue, Female, Fever, Humans, Interferons, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Retrospective Studies, Severity of Illness Index, Tomography, X-Ray Computed, Biomarkers, Coronavirus Infections, Clinical Laboratory Techniques, Ritonavir, Diabetes Complications, Pandemics, Lopinavir
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
